Featured Content

Advances in the Biologic Role of HER2

Chapter 3: Drs. O’Shaughnessy and colleagues discuss the most exciting advances in the biologic role of HER2 in metastatic breast cancer.

Breast Density and Risk Factors Indicate Breast Cancer Screening Intervals

Authors of a modeling study recommend triennial mammography for 12% of women aged 50 years, and 20% aged 65 years with low breast density and ...

Poor Sleep Quality Associated With Symptom Burden Among Phase 1 Trial Participants

Patients who slept poorly exhibited greater symptom burden and overall mood disturbance.

PAP Series: Patient Assistance Programs "Culprits" of Rising Drug Prices

The federal government is investigating some drugmakers' relationships with the charities that run assistance programs.

Gene-expression Prognostic Signatures Guide Adjuvant Chemotherapy of Early-stage Breast Cancer

Gene expression prognostic signatures continue to evolve to provide greater accuracy for both short- and long-term risk of recurrence.

Breast Cancer Resources

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters